New Products, LEO Pharma A/S, Ballerup, Denmark.
Eur J Pharm Biopharm. 2011 Sep;79(1):68-75. doi: 10.1016/j.ejpb.2011.05.012. Epub 2011 May 31.
Treatment of skin diseases implies application of a drug to skin with an impaired epidermal barrier, which is likely to affect the penetration profile of the drug substance as well as the carrier into the skin. To elucidate this, the effect of skin barrier damage on the penetration profile of a corticosteroid applied in solid lipid nanoparticles (SLN) composed of different lipids, varying in polarity, was studied. The studies were carried out in vitro using impaired and intact porcine ear skin, and the SLN were compared with a conventional ointment. It was shown that a significantly higher amount of corticosteroid remained in the skin, intact as well as barrier impaired, when SLN was used as a vehicle. In general, the penetration profile of the drug substance into the skin was affected by the type of lipid used in the formulation and related to lipid polarity and drug substance solubility. When formulated in SLN and applied to intact skin, the permeation of the drug substance across the skin was significantly reduced, as compared to the ointment. Altogether, in both barrier-impaired and intact skin, a higher amount of drug substance remained in the skin during application of SLN for 6, 16, and 24h, as compared to the ointment. These results emphasize the applicability of SLN to create a drug reservoir in skin, with the drug localized distinctively in the stratum corneum.
皮肤病的治疗方法包括将药物应用于表皮屏障受损的皮肤,这可能会影响药物物质以及载体向皮肤中的渗透情况。为了阐明这一点,研究了不同极性的不同脂质组成的固体脂质纳米粒(SLN)中皮质类固醇的渗透情况,以及皮肤屏障损伤对其的影响。这些研究是在体外使用受损和完整的猪耳朵皮肤进行的,将 SLN 与常规软膏进行了比较。结果表明,当 SLN 用作载体时,药物在完整和受损的皮肤中残留的量明显更高。通常,药物物质进入皮肤的渗透情况受到制剂中使用的脂质类型的影响,并且与脂质极性和药物物质的溶解度有关。当以 SLN 形式配制并应用于完整皮肤时,与软膏相比,药物物质穿过皮肤的渗透明显减少。总之,与软膏相比,在屏障受损和完整的皮肤中,在使用 SLN 应用 6、16 和 24 小时期间,药物物质在皮肤中的残留量更高。这些结果强调了 SLN 在皮肤中创建药物库的适用性,使药物在角质层中明显定位。